Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer
Status:
Withdrawn
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether either or both nutrition supplements (Impact®
Advanced Recovery or Boost® High Protein) ingested prior to and during concurrent
chemoradiotherapy decreases toxic side effects of treatment in Stage IIIA-B non-small cell
lung cancer.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborators:
Nestlé Health Science Spain Nestle Health Science US